Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Terumo Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Terumo şirketinin toplam hissedar öz sermayesi ¥1,418.5B ve toplam borcu ¥194.8B olup, bu da borç-öz sermaye oranını 13.7% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ¥1,869.0B ve ¥450.5B dir. Terumo 'in FAVÖK'ü ¥155.6B faiz karşılama oranı -123.8 dur. Şirketin ¥194.9B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

13.7%

Borç/özkaynak oranı

JP¥194.79b

Borç

Faiz karşılama oranı	-123.8x
Nakit	JP¥194.91b
Eşitlik	JP¥1.42t
Toplam yükümlülükler	JP¥450.50b
Toplam varlıklar	JP¥1.87t

Son finansal sağlık güncellemeleri

Terumo (TSE:4543) Has A Pretty Healthy Balance Sheet

Jul 05

Is Terumo (TSE:4543) Using Too Much Debt?

Feb 29

Recent updates

Estimating The Fair Value Of Terumo Corporation (TSE:4543)

Sep 16

Terumo Corporation Just Beat EPS By 12%: Here's What Analysts Think Will Happen Next

Aug 11

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 4543 'nin kısa vadeli varlıkları ( ¥708.8B ) kısa vadeli yükümlülüklerini ( ¥237.8B ) aşıyor.

Uzun Vadeli Yükümlülükler: 4543 şirketinin kısa vadeli varlıkları ( ¥708.8B ) uzun vadeli yükümlülüklerini ( ¥212.7B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 4543 şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: 4543 'nin borç/öz sermaye oranı son 5 yılda 32.1% seviyesinden 13.7% seviyesine düştü.

Borç Kapsamı: 4543 'nin borcu işletme nakit akışı ( 87.6% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 4543 ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.

Terumo Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Terumo (TSE:4543) Has A Pretty Healthy Balance Sheet

Is Terumo (TSE:4543) Using Too Much Debt?

Recent updates

Terumo Corporation to Report Q2, 2025 Results on Nov 07, 2024

Upcoming dividend of JP¥13.00 per share

Estimating The Fair Value Of Terumo Corporation (TSE:4543)

Terumo Corporation (TSE:4543) announces an Equity Buyback for 15,000,000 shares, representing 1.01% for ¥30,000 million.

Terumo Corporation Just Beat EPS By 12%: Here's What Analysts Think Will Happen Next

First quarter 2025 earnings: EPS and revenues exceed analyst expectations

Investor sentiment deteriorates as stock falls 22%

Now 22% undervalued after recent price drop

Investors Still Waiting For A Pull Back In Terumo Corporation (TSE:4543)

Final dividend of JP¥13.00 announced

Full year 2024 earnings: EPS in line with analyst expectations despite revenue beat

Terumo (TSE:4543) Has A Pretty Healthy Balance Sheet

Less than half of directors are independent

Return Trends At Terumo (TSE:4543) Aren't Appealing

Now 20% overvalued

Terumo Corporation to Report Q1, 2025 Results on Aug 08, 2024

Terumo Cardiovascular Announces 510(K) Clearance for the CDI Oneview™? Monitoring System

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target increased by 10% to JP¥3,255

Calculating The Fair Value Of Terumo Corporation (TSE:4543)

Investors Still Waiting For A Pull Back In Terumo Corporation (TSE:4543)

Consensus EPS estimates increase by 11%

Price target increased by 7.4% to JP¥3,136

Terumo (TSE:4543) Has Announced A Dividend Of ¥22.00

New minor risk - Dividend sustainability

Upcoming dividend of JP¥22.00 per share

Terumo Corporation to Report Fiscal Year 2024 Results on May 14, 2024

Is Terumo (TSE:4543) Using Too Much Debt?

Price target increased by 7.3% to JP¥5,548

Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024

Terumo Corporation, Annual General Meeting, Jun 26, 2024

Terumo Corporation to Report Q3, 2024 Results on Feb 07, 2024

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Terumo Corporation to Report Q2, 2024 Results on Nov 14, 2023

Upcoming dividend of JP¥22.00 per share at 1.1% yield

Terumo Corporation (TSE:4543) announces an Equity Buyback for 5,000,000 shares, representing 0.67% for ¥20,000 million.

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Terumo Corporation to Report Q1, 2024 Results on Aug 09, 2023

Terumo Corporation Announces Fiscal Year-End Dividend for the Fiscal Year Ended March 31, 2023, Payable on June 28, 2023; Provides Second Quarter-End Dividend Guidance for the Fiscal Year Ending March 31, 2024 and Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024

Full year 2023 earnings: EPS misses analyst expectations

Terumo Corporation, Annual General Meeting, Jun 27, 2023

Upcoming dividend of JP¥21.00 per share at 1.2% yield

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023

Less than half of directors are independent

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Terumo Corporation Announces Dividend for the Second Quarter End of Fiscal Year 2023, Commences Dividend Payments on December 5, 2022; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

Terumo Corporation to Report Q3, 2023 Results on Nov 10, 2023

Terumo Corporation to Report Q2, 2023 Results on Nov 10, 2022

Upcoming dividend of JP¥18.00 per share

Mitsui DM Sugar Holdings Co.,Ltd. (TSE:2109) agreed to acquire Enteral formula business of Terumo Corporation from Terumo Corporation (TSE:4543).

NUTRI Co.,Ltd. entered into an agreement to acquire Nutritional food and related product assets of Terumo Corporation.

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Terumo Corporation Provides Dividend Guidance for the Second Quarter of Year Ending March 31, 2023

Less than half of directors are independent

Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan

Full year 2022 earnings: EPS misses analyst expectations

Terumo Corporation (TSE:4543) announces an Equity Buyback for 15,000,000 shares, representing 1.98% for ¥50,000 million.

Less than half of directors are independent

Terumo Corporation to Report Fiscal Year 2022 Results on May 12, 2022

Upcoming dividend of JP¥16.00 per share

Third quarter 2022 earnings: EPS misses analyst expectations

Terumo Corporation, Annual General Meeting, Jun 22, 2022

Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022

Second quarter 2022 earnings released: EPS JP¥29.22 (vs JP¥23.63 in 2Q 2021)

Upcoming dividend of JP¥15.00 per share

First quarter 2022 earnings released: EPS JP¥36.90 (vs JP¥18.57 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥102 (vs JP¥114 in FY 2020)

Full year 2021 earnings released: EPS JP¥102 (vs JP¥114 in FY 2020)

Terumo Corporation Provides Dividend Guidance for the Year Ending March 2022

Upcoming dividend of JP¥14.00 per share